POLE, DNA polymerase epsilon catalytic subunit, mediates proofreading activity during DNA repair and replication and plays a role in genomic stability. Somatic mutations in POLE have been identified in colorectal cancer, frequently in endometrial cancer, and are often associated with high tumor mutational burden, but are less likely to be associated with DNA mismatch repair (MMR) deficiency.